Sunrest Lifescience Ltd

NSE: SUNREST

₹39.60

up-down-arrow1.60 (4.21%)

As on 28-Aug-2026IST

Market cap

info icon

₹34 Cr

Revenue (TTM)

info icon

₹71 Cr

P/E Ratio

info icon

8.3

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

SUNREST Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 39.60 High: 40.60

52 Week Range

Low: 27.54 High: 50.33

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹8 Cr

  • ROEROE information

    43.5 %

  • ROCEROCE information

    34.8 %

  • Industry P/EIndustry P/E information

    55.07

  • EV/EBITDAEV/EBITDA information

    3.8

  • Debt to EquityDebt to Equity information

    0.9

  • Book ValueBook Value information

    ₹47.6

  • EPSEPS information

    ₹9.6

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    8,582,400

7 Years Aggregate

CFO

₹-11.96 Cr

EBITDA

₹18.58 Cr

Net Profit

₹13.25 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
SUNREST
2.2 21.4 21.4 -16.4 -- -- --
BSE Healthcare
18.8 2.8 8.7 17.1 23.1 14.8 12.4
As on 28-Aug-2026
Company
2025
2024
SUNREST
-19.3 -18.4
BSE Small Cap
-6.6 29.0
BSE Healthcare
-3.3 43.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
SUNREST
39.6 34.0 70.8 8.0 -- 43.5 8.3 1.0
1,350.2 16,589.5 2,590.4 603.0 29.3 19.6 27.5 4.8
577.7 10,912.7 885.7 234.9 27.8 18 46.5 4.9
1,481.1 15,506.7 1,108.4 270.2 28.3 14.5 56.3 7.5
1,869.4 35,497.5 9,683.5 1,019.0 15.7 21.3 35.1 6.8
23,205.0 29,798.0 2,371.8 497.8 28.0 28.5 59.9 14.7
975.6 5,827.4 942.6 9.9 0.3 1.2 672.4 4.5
1,482.1 6,826.8 691.7 130.8 24.5 14.5 54 7.1
1,152.1 13,020.2 675.6 183.6 32.2 22.7 71.3 14.1
365.0 10,310.7 8.8 -352.4 -4,228.0 -80.8 -- 18.5

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About SUNREST

Manufacture of pharmaceuticals, medicinal chemical and botanical products

  • Incorporated

    2017

  • Chairman

    Juhi Sawajani

  • Managing Director

    Nikhilkumar Y Thakkar

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.sunrestlifescience.com

FAQs for SUNREST

The share price of Sunrest Lifescience Ltd is ₹39.60 (NSE) as of 28-Aug-2026 IST. Sunrest Lifescience Ltd has given a return of -16.37% in the last 1 years.

The P/E ratio of Sunrest Lifescience Ltd is 8.26 times as on 28-Aug-2026, a 85 discount to its peers’ median range of 55.07 times.
The P/B ratio of Sunrest Lifescience Ltd is 0.96 times as on 28-Aug-2026, a 80 discount to its peers’ median range of 4.76 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
3.60
0.72
2025
11.50
1.32
2024
116.07
1.72
2023
0.00
0.00
2022
0.00
0.00

The 52-week high and low of Sunrest Lifescience Ltd are Rs 50.33 and Rs 27.54 as of 30-Aug-2026.

Sunrest Lifescience Ltd has a market capitalisation of ₹ 34 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Sunrest Lifescience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...
loading...